{
  "template_id": "cp-biomarker-thyroid-2016-v1001",
  "organ": null,
  "protocol_posting_date": null,
  "standards": [],
  "sections": [
    {
      "section_id": "thyroid",
      "section_name": "THYROID",
      "fields": [
        {
          "field_id": "note_use_of_this_template_is_optional",
          "label": "Note: Use of this template is optional.",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "specimen_adequacy",
          "label": "SPECIMEN ADEQUACY",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "adequacy_assessment_of_thyroid_fine_needle_aspirates",
          "label": "Adequacy Assessment of Thyroid Fine-Needle Aspirates",
          "required": false,
          "type": "free_text",
          "notes": [
            "A"
          ]
        },
        {
          "field_id": "adequate",
          "label": "___ Adequate",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "inadequate",
          "label": "___ Inadequate",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "suboptimal_explain",
          "label": "___ Suboptimal (explain): ______________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "adequacy_of_resected_specimens_or_cell_blocks_for_testing",
          "label": "Adequacy of Resected Specimens or Cell Blocks for Testing",
          "required": false,
          "type": "free_text",
          "notes": [
            "A"
          ]
        },
        {
          "field_id": "adequate",
          "label": "___ Adequate",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "estimated_tumor_cellularity_area_used_for_testing",
          "label": "Estimated tumor cellularity (area used for testing): ______%",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "suboptimal_explain",
          "label": "___ Suboptimal (explain): ______________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "note_if_adequate_not_selected_please_refer_to_original_laboratory_report_for_explanation",
          "label": "Note: If “Adequate” not selected, please refer to original laboratory report for explanation.",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "results",
          "label": "RESULTS",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "braf_mutational_analysis",
          "label": "BRAF Mutational Analysis",
          "required": false,
          "type": "free_text",
          "notes": [
            "B"
          ]
        },
        {
          "field_id": "no_mutation_detected",
          "label": "___ No mutation detected",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "mutation_identified",
          "label": "___ Mutation identified",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "pv600e_c1799ta",
          "label": "___ p.V600E, c.1799T>A",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "pk601e_c1801ag",
          "label": "___ p.K601E, c.1801A>G",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "other_braf_mutation_specify",
          "label": "___ Other BRAF mutation (specify): ______________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "indicate_mutant_allele_frequency",
          "label": "Indicate mutant allele frequency: ______%",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "cannot_be_determined_explain",
          "label": "___ Cannot be determined (explain): ______________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "tert_mutational_analysis",
          "label": "TERT Mutational Analysis",
          "required": false,
          "type": "free_text",
          "notes": [
            "B"
          ]
        },
        {
          "field_id": "no_mutation_detected",
          "label": "___ No mutation detected",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "mutation_identified",
          "label": "___ Mutation identified",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "c1_124",
          "label": "___ c.1-124",
          "required": false,
          "type": "free_text",
          "condition": "C228T"
        },
        {
          "field_id": "c1_146",
          "label": "___ c.1-146",
          "required": false,
          "type": "free_text",
          "condition": "C250T"
        },
        {
          "field_id": "other_tert_mutation_specify",
          "label": "___ Other TERT mutation (specify): ______________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "cannot_be_determined_explain",
          "label": "___ Cannot be determined (explain): ______________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "nras_mutational_analysis",
          "label": "NRAS Mutational Analysis",
          "required": false,
          "type": "free_text",
          "notes": [
            "C"
          ]
        },
        {
          "field_id": "no_mutation_detected",
          "label": "___ No mutation detected",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "mutation_identified",
          "label": "___ Mutation identified",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "pq61r_c182ag",
          "label": "___ p.Q61R, c.182A>G",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "pq61k_c181ca",
          "label": "___ p.Q61K, c.181C>A",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "other_nras_mutation_specify",
          "label": "___ Other NRAS mutation (specify): ______________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "cannot_be_determined_explain",
          "label": "___ Cannot be determined (explain): ______________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "hras_mutational_analysis",
          "label": "HRAS Mutational Analysis",
          "required": false,
          "type": "free_text",
          "notes": [
            "C"
          ]
        },
        {
          "field_id": "no_mutation_detected",
          "label": "___ No mutation detected",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "mutation_identified",
          "label": "___ Mutation identified",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "pq61r_c182ag",
          "label": "___ p.Q61R, c.182A>G",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "pg12v_c35gt",
          "label": "___ p.G12V, c.35G>T",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "other_hras_mutation_specify",
          "label": "___ Other HRAS mutation (specify): ______________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "cannot_be_determined_explain",
          "label": "___ Cannot be determined (explain): ______________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "kras_mutational_analysis",
          "label": "KRAS Mutational Analysis",
          "required": false,
          "type": "free_text",
          "notes": [
            "C"
          ]
        },
        {
          "field_id": "no_mutation_detected",
          "label": "___ No mutation detected",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "mutation_identified",
          "label": "___ Mutation identified",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "pg12d_c35ga",
          "label": "___ p.G12D, c.35G>A",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "other_kras_mutation_specify",
          "label": "___ Other KRAS mutation (specify): ______________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "cannot_be_determined_explain",
          "label": "___ Cannot be determined (explain): ______________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "akt1_mutational_analysis",
          "label": "AKT1 Mutational Analysis",
          "required": false,
          "type": "free_text",
          "notes": [
            "D"
          ]
        },
        {
          "field_id": "no_mutation_detected",
          "label": "___ No mutation detected",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "mutation_identified",
          "label": "___ Mutation identified",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "pe17k_c49ga",
          "label": "___ p.E17K, c.49G>A",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "other_akt1_mutation_specify",
          "label": "___ Other AKT1 mutation (specify): ______________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "cannot_be_determined_explain",
          "label": "___ Cannot be determined (explain): ______________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "tp53_mutational_analysis",
          "label": "TP53 Mutational Analysis",
          "required": false,
          "type": "free_text",
          "notes": [
            "D"
          ]
        },
        {
          "field_id": "no_mutation_detected",
          "label": "___ No mutation detected",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "mutation_identified_specify",
          "label": "___ Mutation identified (specify): _______________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "cannot_be_determined_explain",
          "label": "___ Cannot be determined (explain): ______________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "pik3ca_mutational_analysis",
          "label": "PIK3CA Mutational Analysis",
          "required": false,
          "type": "free_text",
          "notes": [
            "D"
          ]
        },
        {
          "field_id": "no_mutation_detected",
          "label": "___ No mutation detected",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "mutation_identified",
          "label": "___ Mutation identified",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "ph1047r_c3140ag",
          "label": "___ p.H1047R, c.3140A>G",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "other_pik3ca_mutation_specify",
          "label": "___ Other PIK3CA mutation (specify): ______________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "cannot_be_determined_explain",
          "label": "___ Cannot be determined (explain): ______________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "ctnnb1_β_catenin_mutational_analysis",
          "label": "CTNNB1 (β-catenin) Mutational Analysis",
          "required": false,
          "type": "free_text",
          "notes": [
            "E"
          ]
        },
        {
          "field_id": "no_mutation_detected",
          "label": "___ No mutation detected",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "mutation_identified",
          "label": "___ Mutation identified",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "ps33a_c97tg",
          "label": "___ p.S33A, c.97T>G",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "other_ctnnb1_mutation_specify",
          "label": "___ Other CTNNB1 mutation (specify): ______________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "cannot_be_determined",
          "label": "___ Cannot be determined",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "ret_mutational_analysis",
          "label": "RET Mutational Analysis",
          "required": false,
          "type": "free_text",
          "notes": [
            "F"
          ]
        },
        {
          "field_id": "no_mutation_detected",
          "label": "___ No mutation detected",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "mutation_identified",
          "label": "___ Mutation identified",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "pm918t_c2753tc",
          "label": "___ p.M918T, c.2753T>C",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "other_ret_mutation_specify",
          "label": "___ Other RET mutation (specify): ______________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "mutation_type",
          "label": "Mutation Type",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "germline",
          "label": "___ Germline",
          "required": false,
          "type": "free_text",
          "condition": "inherited"
        },
        {
          "field_id": "somatic",
          "label": "___ Somatic",
          "required": false,
          "type": "free_text",
          "condition": "sporadic"
        },
        {
          "field_id": "unknown",
          "label": "___ Unknown",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "cannot_be_determined_explain",
          "label": "___ Cannot be determined (explain): __________________________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "alk_rearrangement",
          "label": "ALK Rearrangement",
          "required": false,
          "type": "free_text",
          "notes": [
            "G"
          ]
        },
        {
          "field_id": "no_rearrangement_detected",
          "label": "___ No rearrangement detected",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "rearrangement_identified",
          "label": "___ Rearrangement identified",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "strnalk",
          "label": "___ STRN/ALK",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "eml4alk",
          "label": "___ EML4/ALK",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "other_alk_rearrangement_specify",
          "label": "___ Other ALK rearrangement (specify): ______________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "cannot_be_determined_explain",
          "label": "___ Cannot be determined (explain): __________________________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "ntrk1_rearrangement",
          "label": "NTRK1 Rearrangement",
          "required": false,
          "type": "free_text",
          "notes": [
            "H"
          ]
        },
        {
          "field_id": "no_rearrangement_detected",
          "label": "___ No rearrangement detected",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "rearrangement_identified",
          "label": "___ Rearrangement identified",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "ntrk1tpm3",
          "label": "___ NTRK1/TPM3",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "ntrk1tfg",
          "label": "___ NTRK1/TFG",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "other_ntrk1_rearrangement_specify",
          "label": "___ Other NTRK1 rearrangement (specify): ______________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "cannot_be_determined_explain",
          "label": "___ Cannot be determined (explain): __________________________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "ntrk3_rearrangement",
          "label": "NTRK3 Rearrangement",
          "required": false,
          "type": "free_text",
          "notes": [
            "H"
          ]
        },
        {
          "field_id": "no_rearrangement_detected",
          "label": "___ No rearrangement detected",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "rearrangement_identified",
          "label": "___ Rearrangement identified",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "ntrk3etv6",
          "label": "___ NTRK3/ETV6",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "other_ntrk3_rearrangement_specify",
          "label": "___ Other NTRK3 rearrangement (specify): ______________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "cannot_be_determined_explain",
          "label": "___ Cannot be determined (explain): __________________________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "ret_rearrangement",
          "label": "RET Rearrangement",
          "required": false,
          "type": "free_text",
          "notes": [
            "F"
          ]
        },
        {
          "field_id": "no_rearrangement_detected",
          "label": "___ No rearrangement detected",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "rearrangement_identified",
          "label": "___ Rearrangement identified",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "retptc1",
          "label": "___ RET/PTC1",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "retptc3",
          "label": "___ RET/PTC3",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "other_ret_rearrangement_specify",
          "label": "___ Other RET rearrangement (specify): ______________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "cannot_be_determined_explain",
          "label": "___ Cannot be determined (explain): __________________________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "ppar_gamma_rearrangement",
          "label": "PPAR gamma Rearrangement",
          "required": false,
          "type": "free_text",
          "notes": [
            "I"
          ]
        },
        {
          "field_id": "no_rearrangement_detected",
          "label": "___ No rearrangement detected",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "rearrangement_identified",
          "label": "___ Rearrangement identified",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "pax8ppar_gamma",
          "label": "___ PAX8/PPAR gamma",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "creb3l2ppar_gamma",
          "label": "___ CREB3L2/PPAR gamma",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "other_ppar_gamma_rearrangement_specify",
          "label": "___ Other PPAR gamma rearrangement (specify): ______________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "cannot_be_determined_explain",
          "label": "___ Cannot be determined (explain): __________________________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "other_markers_tested",
          "label": "Other Markers Tested",
          "required": false,
          "type": "free_text",
          "condition": "if applicable"
        },
        {
          "field_id": "specify_marker",
          "label": "Specify marker: __________________________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "specify_results",
          "label": "Specify results: __________________________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "methods",
          "label": "METHODS",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "dissection_methods",
          "label": "Dissection Method(s)",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "laser_capture_microdissection",
          "label": "___ Laser capture microdissection",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "specify_test_name",
          "label": "Specify test name#: _____________________________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "manual_under_microscopic_observation",
          "label": "___ Manual under microscopic observation",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "specify_test_name",
          "label": "Specify test name#: _____________________________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "manual_without_microscopic_observation",
          "label": "___ Manual without microscopic observation",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "specify_test_name",
          "label": "Specify test name#: _____________________________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "cored_from_block",
          "label": "___ Cored from block",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "specify_test_name",
          "label": "Specify test name#: _____________________________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "whole_tissue_section",
          "label": "___ Whole tissue section",
          "required": false,
          "type": "free_text",
          "condition": "no tumor enrichment procedure employed"
        },
        {
          "field_id": "specify_test_name",
          "label": "Specify test name#: _____________________________",
          "required": false,
          "type": "free_text",
          "guidance": "If more than 1 dissection method used, please specify which test was associated with each selected dissection method."
        },
        {
          "field_id": "braf_mutational_analysis_testing_methods",
          "label": "BRAF Mutational Analysis Testing Method(s)",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "direct_sanger_sequencing",
          "label": "___ Direct (Sanger) sequencing",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "high_resolution_melting_analysis",
          "label": "___ High-resolution melting analysis",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "next_generation_high_throughput_sequencing",
          "label": "___ Next-generation (high-throughput) sequencing",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "immunohistochemistry",
          "label": "___ Immunohistochemistry",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "ve1_clone",
          "label": "___ VE1 clone",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "other_specify",
          "label": "___ Other (specify): __________________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "other_specify",
          "label": "___ Other (specify): _________________________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "tert_mutational_analysis_testing_method",
          "label": "TERT Mutational Analysis Testing Method",
          "required": false,
          "type": "free_text",
          "condition": "s"
        },
        {
          "field_id": "direct_sanger_sequencing",
          "label": "___ Direct (Sanger) sequencing",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "next_generation_high_throughput_sequencing",
          "label": "___ Next-generation (high-throughput) sequencing",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "other_specify",
          "label": "___ Other (specify): _________________________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "nras_hras_kras_akt1_tp53_and_pik3ca_mutational_analysis_testing_methods",
          "label": "NRAS, HRAS, KRAS, AKT1, TP53, and PIK3CA Mutational Analysis Testing Method(s)",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "direct_sanger_sequencing",
          "label": "___ Direct (Sanger) sequencing",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "high_resolution_melting_analysis",
          "label": "___ High-resolution melting analysis",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "next_generation_high_throughput_sequencing",
          "label": "___ Next-generation (high-throughput) sequencing",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "immunohistochemistry",
          "label": "___ Immunohistochemistry",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "clone_specify",
          "label": "___ Clone (specify): __________________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "other_specify",
          "label": "___ Other (specify): _________________________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "nras_codons_assessed",
          "label": "NRAS Codons Assessed",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "codon_12",
          "label": "___ Codon 12",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "codon_13",
          "label": "___ Codon 13",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "codon_61",
          "label": "___ Codon 61",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "other_specify",
          "label": "___ Other (specify): _________________________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "hras_codons_assessed",
          "label": "HRAS Codons Assessed",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "codon_12",
          "label": "___ Codon 12",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "codon_13",
          "label": "___ Codon 13",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "codon_61",
          "label": "___ Codon 61",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "other_specify",
          "label": "___ Other (specify): _________________________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "kras_codons_assessed",
          "label": "KRAS Codons Assessed",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "codon_12",
          "label": "___ Codon 12",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "codon_13",
          "label": "___ Codon 13",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "codon_61",
          "label": "___ Codon 61",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "other_specify",
          "label": "___ Other (specify): _________________________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "alk_rearrangement_testing_method",
          "label": "ALK Rearrangement Testing Method",
          "required": false,
          "type": "free_text",
          "condition": "s"
        },
        {
          "field_id": "in_situ_hybridization",
          "label": "___ In situ hybridization",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "reverse_transcriptase_polymerase_chain_reaction",
          "label": "___ Reverse transcriptase polymerase chain reaction",
          "required": false,
          "type": "free_text",
          "condition": "RT-PCR"
        },
        {
          "field_id": "immunohistochemistry",
          "label": "___ Immunohistochemistry",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "alk_5a4_clone",
          "label": "___ ALK 5A4 clone",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "alk_d5f3_clone",
          "label": "___ ALK D5F3 clone",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "other_specify",
          "label": "___ Other (specify): _________________________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "next_generation_high_throughput_sequencing",
          "label": "___ Next-generation (high-throughput) sequencing",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "ppar_gamma_rearrangement_testing_method",
          "label": "PPAR gamma Rearrangement Testing Method",
          "required": false,
          "type": "free_text",
          "condition": "s"
        },
        {
          "field_id": "in_situ_hybridization",
          "label": "___ In situ hybridization",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "reverse_transcriptase_polymerase_chain_reaction",
          "label": "___ Reverse transcriptase polymerase chain reaction",
          "required": false,
          "type": "free_text",
          "condition": "RT-PCR"
        },
        {
          "field_id": "immunohistochemistry",
          "label": "___ Immunohistochemistry",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "clone_specify",
          "label": "Clone (specify): _________________________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "next_generation_high_throughput_sequencing",
          "label": "___ Next-generation (high-throughput) sequencing",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "retptc1_retptc3_ntrk1_and_ntrk3_rearrangement_testing_method",
          "label": "RET/PTC1, RET/PTC3, NTRK1, and NTRK3 Rearrangement Testing Method",
          "required": false,
          "type": "free_text",
          "condition": "s"
        },
        {
          "field_id": "in_situ_hybridization",
          "label": "___ In situ hybridization",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "reverse_transcriptase_polymerase_chain_reaction",
          "label": "___ Reverse transcriptase polymerase chain reaction",
          "required": false,
          "type": "free_text",
          "condition": "RT-PCR"
        },
        {
          "field_id": "immunohistochemistry",
          "label": "___ Immunohistochemistry",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "clone_specify",
          "label": "Clone (specify): _________________________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "next_generation_high_throughput_sequencing",
          "label": "___ Next-generation (high-throughput) sequencing",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "ctnnb1_mutational_analysis_testing_method",
          "label": "CTNNB1 Mutational Analysis Testing Method",
          "required": false,
          "type": "free_text",
          "condition": "s"
        },
        {
          "field_id": "direct_sanger_sequencing",
          "label": "___ Direct (Sanger) sequencing",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "next_generation_high_throughput_sequencing",
          "label": "___ Next-generation (high-throughput) sequencing",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "immunohistochemistry",
          "label": "___ Immunohistochemistry",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "clone_specify",
          "label": "Clone (specify): _________________________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "sensitivitylimit_of_mutation_detection",
          "label": "Sensitivity/Limit of Mutation Detection",
          "required": false,
          "type": "free_text",
          "notes": [
            "A"
          ]
        },
        {
          "field_id": "20",
          "label": "___ ≥20%",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "10",
          "label": "___ ≥10%",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "5",
          "label": "___ ≥5%",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "other_specify",
          "label": "___ Other (specify): ________%",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "other_methods_used",
          "label": "Other Methods Used",
          "required": false,
          "type": "free_text",
          "condition": "if applicable"
        },
        {
          "field_id": "specify_method",
          "label": "Specify method: __________________________",
          "required": false,
          "type": "free_text"
        },
        {
          "field_id": "comment",
          "label": "COMMENT",
          "required": false,
          "type": "free_text",
          "condition": "S"
        },
        {
          "field_id": "note_fixative_type_time_to_fixation_cold_ischemia_time_and_time_of_fixation_should_be_reported_if_ap",
          "label": "Note: Fixative type, time to fixation (cold ischemia time), and time of fixation should be reported if applicable in this template or in the original pathology report.",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "gene_names_should_follow_recommendations_of_the_human_genome_organisation_hugo_nomenclature_committe",
          "label": "Gene names should follow recommendations of The Human Genome Organisation (HUGO) Nomenclature Committee (http://hugo-international.org; accessed May 25, 2016).",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "all_reported_gene_sequence_variations_should_be_identified_following_the_recommendations_of_the_huma",
          "label": "All reported gene sequence variations should be identified following the recommendations of the Human Genome Variation Society (http://varnomen.hgvs.org; accessed May 25, 2016).",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "explanatory_notes",
          "label": "Explanatory Notes",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "the_collection_of_material_for_molecular_studies_should_not_affect_the_morphologic_cytologic_assessm",
          "label": "The collection of material for molecular studies should not affect the morphologic cytologic assessment. For fine-needle aspirates (FNA), at the time of the FNA procedure, a small portion of the (residual) aspirated material may be collected into nucleic acids preservative. The material may represent a part of the first needle pass or a separate pass dedicated for the molecular analysis.1 The storage and transportation conditions (time, temperature) have to be specified by laboratories.",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "the_quantity_of_isolated_nucleic_acids_is_the_total_amount_of_extracted_nucleic_acids_the_minimal_ac",
          "label": "The quantity of isolated nucleic acids is the total amount of extracted nucleic acids. The minimal acceptable amount of nucleic acids will depend on the methodology and should be determined by laboratories. The quality of DNA and RNA can be assessed by amplification of housekeeping genes (eg, GAPDH, PGK1). The trouble-shooting procedure for suboptimal specimens should be specified (eg, increasing and decreasing the amount of nucleic acid template).2",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "the_proportion_of_follicular_thyroid_epithelial_cells_in_an_fna_sample_can_be_assessed_by_comparing_",
          "label": "The proportion of follicular thyroid epithelial cells in an FNA sample can be assessed by comparing the expression of the housekeeping gene and a gene known to be expressed predominantly in thyroid follicular cells (eg, keratin 7, thyroid transcription factor 1 [NK2 homeobox 1]), genes expressed in mimics of thyroid nodule (eg, parathyroid hormone), or genes expressed in medullary thyroid carcinoma (ie, calcitonin).3-5",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "the_sensitivity_of_mutation_detection_and_the_method_used_to_establish_sensitivity_should_be_establi",
          "label": "The sensitivity of mutation detection and the method used to establish sensitivity should be established by the laboratory for each methodology (eg, serial dilutions of the positive controls in normal blood/lymphocytes or normal formalin-fixed paraffin-embedded tissue).",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "resection_specimens_may_be_inadequate_due_to_improper_fixation_decalcification_low_tumor_content_or_",
          "label": "Resection specimens may be inadequate due to improper fixation, decalcification, low tumor content, or small tumor size.",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "the_presence_of_braf_v600e_mutation_in_a_fine_needle_aspirate_is_indicative_of_about_99_risk_of_canc",
          "label": "The presence of BRAF V600E mutation in a fine-needle aspirate is indicative of about 99% risk of cancer in the sampled thyroid nodule. When identified alone, BRAF V600E mutation may merely reflect the conventional morphology or tall cell variant of papillary thyroid carcinoma. The combination of BRAF V600E mutation with TERT, AKT1, PIK3CA, or TP53 mutations predicts a more aggressive tumor behavior.6-12 BRAF K601E is an unusual BRAF mutation, which had been reported in follicular variant of papillary thyroid carcinoma and rarely in follicular adenomas.13,14",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "the_finding_of_ras_mutation_in_a_fine_needle_aspirate_is_associated_with_an_about_80_risk_of_cancer_",
          "label": "The finding of RAS mutation in a fine-needle aspirate is associated with an about 80% risk of cancer in a given nodule. The most common types of cancer with RAS mutations are the encapsulated follicular variant of papillary carcinoma and follicular carcinoma. The remaining RAS-positive thyroid nodules are usually diagnosed as follicular adenomas. Sporadic medullary thyroid carcinomas with wild type RET genes may harbor RAS mutations (HRAS or KRAS).2,4,5,8,15,16",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "the_presence_of_ctnnb1_mutation_in_a_given_thyroid_nodule_is_expected_to_confer_a_90_risk_of_cancer_",
          "label": "The presence of CTNNB1 mutation in a given thyroid nodule is expected to confer a >90% risk of cancer. Point mutations in exon 3 of CTNNB1 stabilize the protein by making it insensitive for adenomatous polyposis coli (APC)-induced degradation, leading to the accumulation of β-catenin in the nucleus. In thyroid tumors, mutations in exon 3 of CTNNB1 were also reported in poorly differentiated and anaplastic carcinomas, but not in well-differentiated carcinomas or benign thyroid nodules.18",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "the_presence_of_ret_rearrangements_in_thyroid_fine_needle_aspirate_is_associated_with_95_risk_of_can",
          "label": "The presence of RET rearrangements in thyroid fine-needle aspirate is associated with >95% risk of cancer, most frequently classic papillary thyroid carcinoma. Mutations of the RET gene are typically present in sporadic and familial forms of medullary thyroid carcinoma. Among sporadic medullary carcinomas, RET p.M918T mutation accounts for more than 75% of all somatic RET mutations found in medullary carcinomas.19,20",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "laboratories_should_disclose_whether_the_test_was_performed_on_tissue_type_tumor_versus_normal_tissu",
          "label": "Laboratories should disclose whether the test was performed on tissue type (tumor versus normal tissue) that allows distinguishing between germline (inherited) and sporadic (acquired) mutation. Nevertheless, the distinction between sporadic and germline mutation can be reliably made only by testing a nontumorous specimen, preferably patient blood. Clinical management of patients based on the presence of specific RET mutations has been defined.19,20",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "the_identification_of_alk_fusions_strnalk_or_eml4alk_in_a_thyroid_fna_is_associated_with_a_very_high",
          "label": "The identification of ALK fusions (STRN/ALK or EML4/ALK) in a thyroid FNA is associated with a very high risk of thyroid cancer. ALK fusions were identified in ~1.5% of papillary thyroid carcinomas and in 4% to 9% of dedifferentiated thyroid cancers.21, 22 In advanced papillary thyroid carcinomas and in dedifferentiated thyroid tumors, the presence of an ALK fusion may represent a therapeutic target for crizotinib.21,22",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "rearrangements_of_the_ntrk1_gene_occur_in_5_of_papillary_carcinomas23_different_fusions_partners_of_",
          "label": "Rearrangements of the NTRK1 gene occur in <5% of papillary carcinomas.23 Different fusions partners of NTRK1 have been described including TPM3 and TPR genes. Some studies reported that NTRK1 fusion-positive papillary thyroid carcinomas may have more aggressive biological behavior and higher rate of local recurrence.24 NTRK3 fusions have been reported in papillary thyroid carcinomas.25,26 In vitro studies showed that ETV6/NTRK3 aberrantly activates phosphatidylinositide 3-kinase signaling pathway. A phase 1a/1b clinical trial of the oral TRK Inhibitor LOXO-101 is available.",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "the_presence_of_rearrangements_involving_the_pparg_gene_pax8pparg_and_less_frequently_creb3l2pparg_c",
          "label": "The presence of rearrangements involving the PPARG gene, PAX8/PPARG and less frequently CREB3L2/PPARG, correlate with ~95% risk of cancer, most frequently follicular variant of papillary carcinoma, followed in frequency by follicular carcinoma. Rare cases of follicular adenoma carrying PPARG rearrangements have been reported.27 Most of thyroid cancers positive for PPARG rearrangements are low-grade tumors, whereas 5% to 10% of those tumors have aggressive behavior. Of note, PPARG fusions can be exploited as a therapeutic target for advanced thyroid cancer. The presence of PAX8/PPARG or CREB3L2/PPARG rearrangement in thyroid fine-needle aspirates correlated with >95% risk of cancer, most frequently follicular variant of papillary carcinoma or follicular carcinoma.28",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "references",
          "label": "References",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "1_filie_ac_asa_sl_geisinger_kr_et_al_utilization_of_ancillary_studies_in_thyroid_fine_needle_aspirat",
          "label": "1.\tFilie AC, Asa SL, Geisinger KR, et al. Utilization of ancillary studies in thyroid fine needle aspirates: a synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Diagn Cytopathol. 2008;36(6):438-441.",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "2_nikiforov_ye_steward_dl_robinson_smith_tm_et_al_molecular_testing_for_mutations_in_improving_the_f",
          "label": "2.\tNikiforov YE, Steward DL, Robinson-Smith TM, et al. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab. 2009;94(6):2092-2098.",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "3_alexander_ek_kennedy_gc_baloch_zw_et_al_preoperative_diagnosis_of_benign_thyroid_nodules_with_inde",
          "label": "3.\tAlexander EK, Kennedy GC, Baloch ZW, et al. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. New Engl J Med. 2012;367(8):705-715.",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "4_nikiforov_ye_ohori_np_hodak_sp_et_al_impact_of_mutational_testing_on_the_diagnosis_and_management_",
          "label": "4.\tNikiforov YE, Ohori NP, Hodak SP, et al. Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab. 2011;96(11):3390-3397.",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "5_nikiforov_ye_carty_se_chiosea_si_et_al_highly_accurate_diagnosis_of_cancer_in_thyroid_nodules_with",
          "label": "5.\tNikiforov YE, Carty SE, Chiosea SI, et al. Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay. Cancer. 2014;120(23):3627-3634.",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "6_liu_x_qu_s_liu_r_et_al_tert_promoter_mutations_and_their_association_with_braf_v600e_mutation_and_",
          "label": "6.\tLiu X, Qu S, Liu R, et al. TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer. J Clin Endocrinol Metab. 2014;99(6):E1130-E1136.",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "7_melo_m_da_rocha_ag_vinagre_j_et_al_tert_promoter_mutations_are_a_major_indicator_of_poor_outcome_i",
          "label": "7.\tMelo M, da Rocha AG, Vinagre J, et al. TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas. J Clin Endocrinol Metab. 2014;99(5):E754-E765.",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "8_nikiforova_mn_wald_ai_roy_s_durso_mb_nikiforov_ye_targeted_next_generation_sequencing_panel_thyros",
          "label": "8.\tNikiforova MN, Wald AI, Roy S, Durso MB, Nikiforov YE. Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer. J Clin Endocrinol Metab. 2013;98(11):E1852-E1860.",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "9_ricarte_filho_jc_ryder_m_chitale_da_et_al_mutational_profile_of_advanced_primary_and_metastatic_ra",
          "label": "9.\tRicarte-Filho JC, Ryder M, Chitale DA, et al. Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1. Cancer Res. 2009;69(11):4885-4893.",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "10_xing_m_liu_r_liu_x_et_al_braf_v600e_and_tert_promoter_mutations_cooperatively_identify_the_most_a",
          "label": "10.\tXing M, Liu R, Liu X, et al. BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence. J Clin Oncol. 2014;32(25):2718-2726.",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "11_xing_m_clark_d_guan_h_et_al_braf_mutation_testing_of_thyroid_fine_needle_aspiration_biopsy_specim",
          "label": "11.\tXing M, Clark D, Guan H, et al. BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer. J Clin Oncol. 2009;27(18):2977-2982.",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "12_the_cancer_genome_atlas_research_network_integrated_genomic_characterization_of_papillary_thyroid",
          "label": "12.\tThe Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014;159(3):676-690.",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "13_park_jy_kim_wy_hwang_ts_et_al_braf_and_ras_mutations_in_follicular_variants_of_papillary_thyroid_",
          "label": "13.\tPark JY, Kim WY, Hwang TS, et al. BRAF and RAS mutations in follicular variants of papillary thyroid carcinoma. Endocr Pathol. 2013;24(2):69-76.",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "14_chiosea_s_nikiforova_m_zuo_h_et_al_a_novel_complex_braf_mutation_detected_in_a_solid_variant_of_p",
          "label": "14.\tChiosea S, Nikiforova M, Zuo H, et al. A novel complex BRAF mutation detected in a solid variant of papillary thyroid carcinoma. Endocr Pathol. 2009;20(2):122-126.",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "15_gupta_n_dasyam_ak_carty_se_et_al_ras_mutations_in_thyroid_fna_specimens_are_highly_predictive_of_",
          "label": "15.\tGupta N, Dasyam AK, Carty SE, et al. RAS mutations in thyroid FNA specimens are highly predictive of predominantly low-risk follicular-pattern cancers. J Clin Endocrinol Metab. 2013;98(5):E914-E922.",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "16_boichard_a_croux_l_al_ghuzlan_a_et_al_somatic_ras_mutations_occur_in_a_large_proportion_of_sporad",
          "label": "16.\tBoichard A, Croux L, Al Ghuzlan A, et al. Somatic RAS mutations occur in a large proportion of sporadic RET-negative medullary thyroid carcinomas and extend to a previously unidentified exon. J Clin Endocrinol Metab. 2012;97(10):E2031-E2035.",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "17_dobashi_y_sugimura_h_sakamoto_a_et_al_stepwise_participation_of_p53_gene_mutation_during_dediffer",
          "label": "17.\tDobashi Y, Sugimura H, Sakamoto A, et al. Stepwise participation of p53 gene mutation during dedifferentiation of human thyroid carcinomas. Diagn Mol Pathol. 1994;3(1):9-14.",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "18_garcia_rostan_g_camp_rl_herrero_a_carcangiu_ml_rimm_dl_tallini_g_beta_catenin_dysregulation_in_th",
          "label": "18.\tGarcia-Rostan G, Camp RL, Herrero A, Carcangiu ML, Rimm DL, Tallini G. Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis. Am J Pathol. 2001;158(3):987-996.",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "19_de_groot_jw_links_tp_plukker_jt_lips_cj_hofstra_rm_ret_as_a_diagnostic_and_therapeutic_target_in_",
          "label": "19.\tde Groot JW, Links TP, Plukker JT, Lips CJ, Hofstra RM. RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors. Endocrine Rev. 2006;27(5):535-560.",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "20_kloos_rt_eng_c_evans_db_et_al_medullary_thyroid_cancer_management_guidelines_of_the_american_thyr",
          "label": "20.\tKloos RT, Eng C, Evans DB, et al. Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid. 2009;19(6):565-612.",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "21_kelly_lm_barila_g_liu_p_et_al_identification_of_the_transforming_strn_alk_fusion_as_a_potential_t",
          "label": "21.\tKelly LM, Barila G, Liu P, et al. Identification of the transforming STRN-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer. Proc Nat Acad Sci USA. 2014;111(11):4233-4238.",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "22_demeure_mj_aziz_m_rosenberg_r_gurley_sd_bussey_kj_carpten_jd_whole_genome_sequencing_of_an_aggres",
          "label": "22.\tDemeure MJ, Aziz M, Rosenberg R, Gurley SD, Bussey KJ, Carpten JD. Whole-genome sequencing of an aggressive BRAF wild-type papillary thyroid cancer identified EML4-ALK translocation as a therapeutic target. World J Surg. 2014;38(6):1296-1305.",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "23_greco_a_miranda_c_pierotti_ma_rearrangements_of_ntrk1_gene_in_papillary_thyroid_carcinoma_mol_cel",
          "label": "23.\tGreco A, Miranda C, Pierotti MA. Rearrangements of NTRK1 gene in papillary thyroid carcinoma. Mol Cell Endocrinol. 2010;321(1):44-49.",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "24_musholt_tj_musholt_pb_khaladj_n_schulz_d_scheumann_gf_klempnauer_j_prognostic_significance_of_ret",
          "label": "24.\tMusholt TJ, Musholt PB, Khaladj N, Schulz D, Scheumann GF, Klempnauer J. Prognostic significance of RET and NTRK1 rearrangements in sporadic papillary thyroid carcinoma. Surgery. 2000;128(6):984-993.",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "25_leeman_neill_rj_kelly_lm_liu_p_et_al_etv6_ntrk3_is_a_common_chromosomal_rearrangement_in_radiatio",
          "label": "25.\tLeeman-Neill RJ, Kelly LM, Liu P, et al. ETV6-NTRK3 is a common chromosomal rearrangement in radiation-associated thyroid cancer. Cancer. 2014;120(6):799-807.",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "27_nikiforov_ye_nikiforova_mn_molecular_genetics_and_diagnosis_of_thyroid_cancer_nat_rev_endocrinol_",
          "label": "27.\tNikiforov YE, Nikiforova MN. Molecular genetics and diagnosis of thyroid cancer. Nat Rev Endocrinol. 2011(11);7:569-580.",
          "required": true,
          "type": "free_text"
        },
        {
          "field_id": "28_lui_wo_zeng_l_rehrmann_v_et_al_creb3l2_ppargamma_fusion_mutation_identifies_a_thyroid_signaling_p",
          "label": "28.\tLui WO, Zeng L, Rehrmann V, et al. CREB3L2-PPARgamma fusion mutation identifies a thyroid signaling pathway regulated by intramembrane proteolysis. Cancer Res. 2008;68(17):7156-7164.",
          "required": true,
          "type": "free_text"
        }
      ]
    }
  ]
}